Have Questions?
Get Answers.


Contact Customer Service

Call: 1-800-543-1980

Email Us

-or-

Contact Technical Support

Call: 1-800-343-3858

Email Us

Sign Up for
Email Updates

Stay connected with the latest product information & company news
Register Now View Privacy Policy
Webinars
Detecting Clostridium difficile: What are the Recommendations and What are our Options?

This program will provide a comprehensive overview of Clostridium difficile and the clinical benefits of utilizing molecular technology for detection.
Key opinion leader, Katelijne Flore, M.D. presents the topic of Molecular Biology in the Diagnosis of Clostridium difficile

Worldwide, Clostridium difficile continues to be a leading cause of hospital acquired infections. C. difficile key opinion leader, Katelijne Floré, M.D. presents the topic of Molecular Biology in the Diagnosis of Clostridium difficile.
Program focusing on the experience of using Illumigene C. difficile for testing

Worldwide, Clostridium difficile continues to be a leading cause of hospital acquired infections. This program will focus on the experience of using illumigene® C. difficile for testing. The performance compared to culture and the benefits of a rapid turnaround time will also be discussed.
Key opinion leader Wallace Greene, PhD, (ABMM) presents the topic - Detecting Clostridium difficile

C. difficile key opinion leader Wallace Greene, PhD, (ABMM) presents the topic - Detecting Clostridium difficile and addressing what are the recommendations and what are your options for testing.
Key opinion leader Romney Humphries, PhD M(ASCP)CM discusses the UCLA experience with C. difficile disease testing

C. difficile key opinion leader Romney Humphries, PhD M(ASCP)CM discusses the UCLA experience with C. difficile disease testing. Topics include a review of current available diagnostic testing options for C. difficile, ASM guidelines, lab testing algorithms, the illumigene® C. difficile molecular assay, and why UCLA chose the illumigene® test method.
Key opinion leader Erik. R. Dubberke, MD, MSPS speaks about the clinical and economic implications of the disease

C. difficile key opinion leader Erik. R. Dubberke, MD, MSPS speaks about the clinical and economic implications of the disease. Topics discussed include assessing attributable outcomes, C. difficile attributable outcomes (Costs, Morbidity, and Mortality), epidemic strain and outcomes, and laboratory role to improve outcomes.
C. difficile key opinion leader Kim M. Ware, RN, BSN, CIC speaks about the bacteria

C. difficile key opinion leader Kim M. Ware, RN, BSN, CIC speaks about the bacteria. Topics discussed include lessons from an outbreak, highlights from the APIC Prevalence Study, IC Practice Recommendations, and the future of C. difficile.
C. difficile key opinion leader Stephen M. Brecher PhD, DABMM, FAAM discusses the management of the bacteria in community settings

C. difficile key opinion leader Stephen M. Brecher PhD, DABMM, FAAM discusses the management of the bacteria in community settings. Topics discussed include case reports, historical prospective, organism and key properties, changing epidemiology, diagnosis and treatment, and infection control.

Featured Products
Illumigene Molecular Diagnostic System NEW molecular assay for the detection of C. difficile in stool
View Product
ELISA for the detection of C. difficile toxins A & B in stool specimens ELISA for the detection of C. difficile toxins A&B in stool specimens.
View Product
Rapid EIA for the detection of C. difficile toxins A & B in stool specimens Rapid EIA for the detection of C. difficile toxins A&B in stool specimens
View Product
An enzyme immunoassay for the detection of C. difficile common antigen (GCH) An enzyme immunoassay for the detection of C. difficile common antigen (GCH).
View Product
  pixel